Creative Planning Arrowhead Pharmaceuticals, Inc. Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Creative Planning holds 25,409 shares of ARWR stock, worth $527,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,409

Previous 28,276 10.14%

Holding current value

$527,490

Previous $734,000 33.11%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$19.36 - $29.54 $55,505 - $84,691	-2,867 Reduced 10.14%	25,409 $491,000
Q2 2024 Aug 15, 2024	BUY	$21.87 - $28.24 $52,925 - $68,340	2,420 Added 9.36%	28,276 $734,000
Q1 2024 May 10, 2024	BUY	$27.21 - $39.48 $202,850 - $294,323	7,455 Added 40.51%	25,856 $739,000
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $26,775 - $39,190	1,263 Added 7.37%	18,401 $563,000
Q3 2023 Nov 16, 2023	SELL	$26.2 - $36.08 $24,863 - $34,239	-949 Reduced 5.25%	17,138 $460,000
Q2 2023 Jul 21, 2023	BUY	$25.16 - $41.38 $93,393 - $153,602	3,712 Added 25.82%	18,087 $644,000
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $23,182 - $37,701	-979 Reduced 6.38%	14,375 $365,000
Q4 2022 Feb 10, 2023	BUY	$28.0 - $40.56 $21,308 - $30,866	761 Added 5.21%	15,354 $622,000
Q3 2022 Nov 03, 2022	BUY	$29.63 - $48.31 $22,222 - $36,232	750 Added 5.42%	14,593 $482,000
Q2 2022 Aug 15, 2022	BUY	$27.79 - $50.61 $33,542 - $61,086	1,207 Added 9.55%	13,843 $487,000
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $2,297 - $4,058	58 Added 0.46%	12,636 $581,000
Q4 2021 Feb 11, 2022	SELL	$58.09 - $82.51 $43,277 - $61,469	-745 Reduced 5.59%	12,578 $834,000
Q3 2021 Nov 10, 2021	BUY	$58.38 - $84.96 $43,785 - $63,719	750 Added 5.97%	13,323 $832,000
Q2 2021 Aug 04, 2021	BUY	$62.15 - $90.32 $203,354 - $295,527	3,272 Added 35.18%	12,573 $1.04 Million
Q1 2021 Apr 30, 2021	BUY	$61.35 - $90.47 $38,773 - $57,177	632 Added 7.29%	9,301 $617,000
Q4 2020 Jan 29, 2021	BUY	$43.82 - $85.37 $13,847 - $26,976	316 Added 3.78%	8,669 $665,000
Q2 2020 Jul 23, 2020	SELL	$26.12 - $43.27 $60,546 - $100,299	-2,318 Reduced 21.72%	8,353 $361,000
Q1 2020 May 05, 2020	SELL	$20.56 - $63.12 $39,166 - $120,243	-1,905 Reduced 15.15%	10,671 $307,000
Q4 2019 Jan 30, 2020	SELL	$28.14 - $73.01 $12,972 - $33,657	-461 Reduced 3.54%	12,576 $798,000
Q3 2019 Nov 01, 2019	SELL	$26.26 - $34.86 $12,210 - $16,209	-465 Reduced 3.44%	13,037 $367,000
Q2 2019 Jul 26, 2019	BUY	$17.43 - $28.82 $47,671 - $78,822	2,735 Added 25.4%	13,502 $358,000
Q1 2019 Apr 24, 2019	SELL	$12.05 - $20.18 $122,428 - $205,028	-10,160 Reduced 48.55%	10,767 $198,000
Q4 2018 Feb 01, 2019	BUY	$10.74 - $19.7 $224,755 - $412,261	20,927 New	20,927 $260,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.5M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.2B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Arrowhead Pharmaceuticals, Inc. Transaction History